https://www.selleckchem.com/pr....oducts/ecc5004-azd50
Knocking out catalase results in P-AscH- radio-sensitization in PDACs. In a phase I trial where P-AscH- was included as an adjuvant to the standard of care, short-term survivors had higher catalase levels in tumor tissue, compared to long-term survivors. These data suggest that P-AscH- radio-sensitizes PDACs through increased peroxide flux. Catalase levels could be a possible indicator for how tumors will respond to P-AscH-.Coronavirus disease 2019 (COVID-19) vaccination has recently started worldwide. As the vaccine supply will
Curtir
Comentario
Compartilhar
